Blog
RSS FeedPosted by Michael Wonder on 10 Aug 2019
Government of Canada announces changes to lower drug prices and lay the foundation for National Pharmacare
9 August 2019 - Today, the Government of Canada announced the final amendments to the Patented Medicines Regulations. ...
Posted by Michael Wonder on 06 Aug 2019
Knight Therapeutics and pan-Canadian Pharmaceutical Alliance reach agreement for Probuphine for opioid dependence
6 August 2019 - AB, SK and NIHB are the first public drug plans to fund Probuphine recognising benefits of new ...
Posted by Michael Wonder on 02 Aug 2019
Trudeau pledges ‘steady’ drug supply in Canada amid concerns over Trump policy
1 August 2019 - Canadians will continue to have access to the medications they need, Prime Minister Justin Trudeau promised ...
Posted by Michael Wonder on 01 Aug 2019
Proposal to enhance the transparency of CADTH’s review reports and recommendations
31 July 2019 - CADTH is committed to increasing the transparency of its health technology assessment processes. ...
Posted by Michael Wonder on 31 Jul 2019
Two powerful Canadian provinces argued against federal drug price crackdown
31 July 2019 - Canada’s two most populous provinces, Ontario and Quebec, have privately expressed concerns with a federal government plan ...
Posted by Michael Wonder on 31 Jul 2019
Could Quebec’s public drug plan work for national pharmacare?
30 July 2019 - Quebec’s universal pharmacare program offers better drug coverage and quicker approval for new drugs coming to ...
Posted by Michael Wonder on 25 Jul 2019
Quebec’s public-private pharmacare model provides more generous—and timely—access to new drugs
25 July 2019 - Quebec’s universal pharmacare system, which relies on both a public plan and private insurance providers, covers ...
Posted by Michael Wonder on 22 Jul 2019
Should national pharmacare apply a value based insurance design?
22 July 2019 - The final report of the Advisory Council on the Implementation of National Pharmacare, published in June 2019, ...
Posted by Michael Wonder on 20 Jul 2019
Biosimilar drugs a boon to be applauded as they provide equivalent treatment at – sometimes – half the price
19 July 2019 - The fastest-growing segment of our health-care system is prescription drugs – now constituting the second-highest category ...
Posted by Michael Wonder on 18 Jul 2019
Canada warns U.S. against drug import plans, citing shortage concerns
18 July 2019 - Canada opposes any U.S. plans to buy Canadian prescription drugs that might threaten the country’s drug supply ...
Posted by Michael Wonder on 10 Jul 2019
Canada’s labour leaders encourage premiers to embrace universal pharmacare
10 July 2019 - The presidents of federations of labour from across the country are in Saskatoon during the Council ...
Posted by Michael Wonder on 10 Jul 2019
New committee brings diverse patient, family, and caregiver voices to CADTH
10 July 2019 - Following a nationwide call for nominations, CADTH is pleased to announce the membership of its new ...
Posted by Michael Wonder on 07 Jul 2019
Life-changing drug Spinraza still not covered for many Canadians with spinal muscular atrophy
4 July 2019 - For several hundred Canadians with spinal muscular atrophy, Spinraza is a drug that means the difference ...
Posted by Michael Wonder on 27 Jun 2019
Canada’s ‘Pharmacare’ idea will face the same obstacles as Obamacare
27 June 2019 - Canadians have long viewed their single payer health care system with a near-religious reverence, largely because ...
Posted by Michael Wonder on 26 Jun 2019
Pharmacare in Canada remains an idealistic pitch, without a realistic plan
26 June 2019 - We still haven't figured out how to make health care truly universal. ...